Free Trial

Takeda Pharmaceutical (TAK) Institutional Ownership

Takeda Pharmaceutical logo
$18.11 +0.31 (+1.71%)
Closing price 03:59 PM Eastern
Extended Trading
$17.87 -0.24 (-1.33%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Takeda Pharmaceutical (NYSE:TAK)

Current
Institutional Ownership
Percentage
9.17%
Number of
Institutional Buyers
(last 12 months)
177
Total
Institutional Inflows
(last 12 months)
$246.17M
Number of
Institutional Sellers
(last 12 months)
108
Total
Institutional Outflows
(last 12 months)
$207.60M
Get TAK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Takeda Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TAK Institutional Buying and Selling by Quarter

Takeda Pharmaceutical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/2/2026 Versant Capital Management Inc43,260$787K0.1%+1.3%0.001%
9/23/2026QRG Capital Management Inc.372,752$5.98M0.0%+1.4%0.012%
9/23/2026Envestnet Portfolio Solutions Inc.12,997$208K0.0%-10.6%0.000%
9/9/2026Sequoia Financial Advisors LLC87,929$1.41M0.0%-11.1%0.003%
9/9/2026Tidal Investments LLC59,554$955K0.0%-1.7%0.002%
9/9/2026Engineers Gate Manager LP44,396$712K0.0%N/A0.001%
9/9/2026Integrated Wealth Concepts LLC17,872$286K0.0%N/A0.001%
9/8/2026Allworth Financial LP13,516$217K0.0%+6.1%0.000%
9/8/2026West Family Investments Inc.17,557$281K0.1%+12.5%0.001%
8/27/2026Corient Private Wealth LP73,053$1.17M0.0%-9.1%0.002%
8/23/2026HB Wealth Management LLC15,484$248K0.0%-9.2%0.000%
8/23/2026Angeles Wealth Management LLC17,800$289K0.0%+31.5%0.001%
8/22/2026Syon Capital LLC45,459$729K0.0%-12.0%0.001%
8/22/2026Concurrent Investment Advisors LLC11,890$191K0.0%N/A0.000%
8/21/2026Natural Investments LLC17,230$276K0.1%+3.6%0.001%
7/10/2026Fulton Bank N.A.14,069$226K0.0%-7.6%0.000%
7/9/2026Legacy Wealth Asset Management LLC160,171$2.57M0.6%-3.4%0.005%
7/9/2026Valeo Financial Advisors LLC10,141$163K0.0%N/A0.000%
7/7/2026GAMMA Investing LLC13,837$222K0.0%+10.7%0.000%
7/2/2026 Versant Capital Management Inc42,686$684K0.1%+10.8%0.001%
6/3/2026Parallel Advisors LLC24,651$457K0.0%+10.5%0.001%
5/26/2026Glenmede Trust Co. NA30,205$559K0.0%+9.6%0.001%
5/19/2026Bank of America Corp DE319,969$5.93M0.0%-11.8%0.010%
5/18/2026EverSource Wealth Advisors LLC25,896$480K0.0%+95.8%0.001%
5/18/2026Royal Bank of Canada614,851$11.39M0.0%+11.0%0.019%
5/16/2026Quantinno Capital Management LP1,289,326$23.88M0.0%+20.6%0.041%
5/14/2026Renaissance Technologies LLC2,989,100$55.36M0.1%+14.2%0.094%
5/14/2026Compound Planning Inc.59,618$1.10M0.0%+30.5%0.002%
5/14/2026Keebeck Wealth Management12,647$234K0.0%N/A0.000%
5/14/2026Arrowstreet Capital Limited Partnership3,116,311$57.71M0.0%-45.2%0.098%
5/14/2026Sei Investments Co.229,943$4.26M0.0%+20.3%0.007%
5/14/2026Lido Advisors LLC22,886$424K0.0%-17.4%0.001%
5/13/2026Cetera Investment Advisers224,015$4.15M0.0%+7.2%0.007%
5/13/2026First Trust Advisors LP1,971,074$36.50M0.0%-17.3%0.062%
5/8/2026PNC Financial Services Group Inc.56,714$1.05M0.0%-3.7%0.002%
5/8/2026Summit Global Investments116,494$2.16M0.1%+11.6%0.004%
5/7/2026Dimensional Fund Advisors LP135,679$2.51M0.0%-16.9%0.004%
5/7/2026Parallel Advisors LLC24,651$457K0.0%+10.5%0.001%
5/7/2026Arjuna Capital62,195$1.15M0.3%+2.0%0.002%
5/6/2026Assetmark Inc.227,616$4.22M0.0%+45.8%0.007%
They're not telling you how bad this could get (Ad)

Valuations have reached levels seen only a handful of times in the past century, while debt concerns and tariff-driven supply chain shocks continue to build beneath market headlines. Parkview Capital's new Market Crash Survival Guide breaks down what's happening under the surface and how investors are positioning their retirement savings in response.tc pixel

Download the free Market Crash Survival Guide now to protect your retirement savings.
5/6/2026Gallacher Capital Management LLC24,520$454K0.2%+13.1%0.001%
5/6/2026Angeles Wealth Management LLC13,535$251K0.0%+16.5%0.000%
5/6/2026Allspring Global Investments Holdings LLC28,944$542K0.0%+41.9%0.001%
5/5/2026Bank of New York Mellon Corp129,335$2.40M0.0%+16.4%0.004%
5/5/2026Sanctuary Advisors LLC29,457$546K0.0%+24.7%0.001%
5/5/2026Checchi Capital Advisers LLC14,591$270K0.0%+5.7%0.000%
5/4/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management45,942$851K0.0%-2.0%0.001%
5/4/2026Bleakley Financial Group LLC431,602$7.99M0.1%+19.0%0.014%
5/1/2026Sequoia Financial Advisors LLC98,936$1.83M0.0%+18.9%0.003%
5/1/2026Manning & Napier Advisors LLC218,977$4.06M0.1%+1.5%0.007%
4/29/2026Jackson Thornton Wealth Management LLC14,360$260K0.0%+9.4%0.000%
4/28/2026Kathmere Capital Management LLC15,932$295K0.0%+44.3%0.001%
4/28/2026Abel Hall LLC34,099$632K0.1%+2.3%0.001%
4/28/2026DGS Capital Management LLC23,106$428K0.1%+63.1%0.001%
4/28/2026Walkner Condon Financial Advisors LLC10,021$186K0.0%N/A0.000%
4/28/2026QRG Capital Management Inc.367,688$6.81M0.1%+27.3%0.012%
4/27/2026HB Wealth Management LLC17,055$316K0.0%+41.9%0.001%
4/27/2026Private Advisor Group LLC26,488$491K0.0%+17.2%0.001%
4/27/2026Elevation Point Wealth Partners LLC141,882$2.63M0.1%+376.3%0.004%
4/25/2026Keybank National Association OH39,215$726K0.0%+205.3%0.001%
4/25/2026Pzena Investment Management LLC28,360$525K0.0%+37.5%0.001%
4/24/2026Fulton Bank N.A.15,234$282K0.0%N/A0.000%
4/21/2026SmartHarvest Portfolios LLC13,905$258K0.1%+34.8%0.000%
4/21/2026Aaron Wealth Advisors LLC43,791$811K0.0%+44.7%0.001%
4/20/2026Ritholtz Wealth Management53,205$985K0.0%+123.1%0.002%
4/20/2026Blue Trust Inc.6,412$119K0.0%-48.1%0.000%
4/17/2026Anchyra Partners LLC12,466$231K0.1%N/A0.000%
4/16/2026SG Americas Securities LLC7,065$131K0.0%-49.0%0.000%
4/16/2026Evolve Private Wealth LLC26,029$482K0.0%+4.5%0.001%
3/17/2026Rockefeller Capital Management L.P.5,184$81K0.0%+30.6%0.000%
3/11/2026Larry Mathis Financial Planning LLC14,343$224K0.2%N/A0.000%
3/9/2026Corient Private Wealth LLC76,483$1.19M0.0%-31.8%0.002%
3/4/2026Pure Financial Advisors LLC10,528$164K0.0%N/A0.000%
3/4/2026SHP Wealth Management2,695$42K0.0%N/A0.000%
3/4/2026Keenan LLC17,513$273K0.2%N/A0.001%
2/24/2026DGS Capital Management LLC14,170$221K0.0%-17.5%0.000%
2/24/2026SG Trading Solutions LLC43,758$682K0.2%N/A0.001%
2/20/2026Keenan LLC10,941$171K9.8%N/A0.000%
2/19/2026Compound Planning Inc.45,673$712K0.0%+8.3%0.001%
2/19/2026Corient Private Wealth LLC91,363$1.38M0.0%-18.5%0.003%
2/18/2026Mercer Global Advisors Inc. ADV175,738$2.74M0.0%-17.3%0.006%
2/18/2026Summit Global Investments104,373$1.63M0.1%+22.5%0.003%
2/18/2026Vident Advisory LLC59,135$922K0.0%-30.2%0.002%
2/18/2026EP Wealth Advisors LLC23,081$360K0.0%N/A0.001%
2/18/2026XTX Topco Ltd71,476$1.11M0.0%+437.7%0.002%
2/18/2026Voloridge Investment Management LLC962,502$15.01M0.1%+1,070.7%0.030%
2/18/2026Toronto Dominion Bank823,200$12.83M0.0%-72.6%0.026%
2/18/2026Evolve Private Wealth LLC24,904$388K0.0%N/A0.001%
2/18/2026Engineers Gate Manager LP41,134$641K0.0%+26.0%0.001%
2/18/2026Balyasny Asset Management L.P.141,024$2.20M0.0%N/A0.004%
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before December 8th
2/17/2026Schonfeld Strategic Advisors LLC115,250$1.80M0.0%N/A0.004%
2/17/2026AQR Capital Management LLC679,277$10.59M0.0%-11.4%0.021%
2/17/2026Abel Hall LLC33,318$519K0.1%N/A0.001%
2/17/2026Cetera Investment Advisers208,922$3.26M0.0%-2.0%0.007%
2/17/2026Equitable Holdings Inc.10,840$169K0.0%-44.4%0.000%
2/17/2026Rexford Capital Inc.8,585$134K0.1%-7.0%0.000%
2/17/2026Laird Norton Wetherby Trust Company LLC50,212$783K0.0%N/A0.002%
2/17/2026Kotler Kevin20,000$312K0.1%N/A0.001%
2/17/2026Osaic Holdings Inc.13,967$218K0.0%-33.0%0.000%
2/17/2026Regal Investment Advisors LLC28,698$447K0.0%N/A0.001%


TAK Institutional Ownership - Frequently Asked Questions

During the previous two years, 310 institutional investors and hedge funds held shares of Takeda Pharmaceutical. The most heavily invested institutionals were Capital Research Global Investors ($210.26M), Morgan Stanley ($99.36M), Goldman Sachs Group Inc. ($74.90M), UBS Group AG ($64.29M), Brandes Investment Partners LP ($60.52M), Arrowstreet Capital Limited Partnership ($57.71M), and Renaissance Technologies LLC ($55.36M).Learn more on Takeda Pharmaceutical's institutional investors.

9.17% of Takeda Pharmaceutical's stock is owned by institutional investors. Learn more on TAK's institutional investor holdings.

Of the 281 institutional investors that purchased Takeda Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Arrowstreet Capital Limited Partnership ($4.46M), Adage Capital Partners GP L.L.C. ($3.43M), UBS Group AG ($1.87M), Qube Research & Technologies Ltd ($1.48M), Van ECK Associates Corp ($1.31M), Voloridge Investment Management LLC ($1.09M), and Toronto Dominion Bank ($1.02M).

Institutional investors have bought a total of 15,981,086 shares in the last 24 months. This purchase volume represents approximately $246.17M in transactions.

Of the 108 institutional investors that sold Takeda Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Arrowstreet Capital Limited Partnership ($2.57M), Toronto Dominion Bank ($2.18M), UBS Group AG ($1.77M), Morgan Stanley ($1.32M), Renaissance Technologies LLC ($1.25M), Bank of America Corp DE ($711.71K), and First Trust Advisors LP ($630.73K).

Institutional investors have sold a total of 12,846,518 shares in the last 24 months. This volume of shares sold represents approximately $207.60M in transactions.



Institutional ownership data for NYSE:TAK is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/2/2026. New 13F filings are added each quarter as they're published.
From Our Partners